首頁 > 市場調查報告書 > 製藥

催產素市場規模、佔有率和成長分析（按適應症、通路、給藥途徑和地區分類）－2026-2033年產業預測

市場調查報告書

商品編碼

1915915

催產素市場規模、佔有率和成長分析（按適應症、通路、給藥途徑和地區分類）－2026-2033年產業預測

Oxytocin Market Size, Share, and Growth Analysis, By Indication (Antepartum, Postpartum), By Distribution Channel (Hospitals, Pharmacies), By Route of Administration, By Region - Industry Forecast 2026-2033

出版日期: 2026年01月02日 | 出版商:

SkyQuest | 英文 173 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

預計到 2024 年，全球催產素市場規模將達到 43.1 億美元，到 2025 年將達到 45.3 億美元，到 2033 年將達到 67.4 億美元，在預測期（2026-2033 年）內，複合年成長率為 5.1%。

全球催產素市場受到分娩併發症增加以及發展中地區對孕產婦健康日益重視的顯著影響。人們對安全分娩管理技術的認知不斷提高，以及催產素在引產和產後出血治療中的應用日益廣泛，正在推動市場擴張。注射劑和滴鼻劑等多種給藥途徑的引入，提高了藥物的可及性，並滿足了患者的偏好。一個值得關注的趨勢是，市場正轉向使用合成催產素和生物相似藥，這些產品因其品質穩定、污染風險低而備受青睞。然而，該市場也面臨許多挑戰，例如嚴格的監管流程、安全隱患以及成本壁壘，尤其是在低收入地區。此外，來自替代藥物和草藥的競爭也可能限制催產素的市場佔有率。

全球催產素市場促進因素

全球催產素市場的主要促進因素之一是各種產科併發症的增加以及對更安全分娩技術的需求日益成長。催產素在產科廣泛用於引產、減少產後出血和刺激子宮收縮，進而改善母嬰健康。此外，醫護人員對催產素在處理分娩併發症的重要性認知不斷提高，也推動了醫院和產科診所對催產素的應用。同時，對催產素在分娩以外領域（包括精神疾病和社會行為）潛在治療應用的研究不斷深入，也促進了市場成長。

全球催產素市場限制因素

全球催產素市場的主要限制因素之一是其生產和醫療用途受到嚴格監管。監管機構制定了嚴格的安全性和有效性標準，這可能會延緩新配方和療法的核准流程，從而限制創新催產素治療方法的普及。此外，人們也擔心催產素在非監管領域（尤其是在農業和獸醫領域）被濫用，這進一步加劇了法律規範性。這可能會抑制對催產素市場的投資和研究，最終阻礙市場成長，並限制那些可能受益於此類治療方法的患者獲得治療的機會。

全球催產素市場趨勢

全球催產素市場正經歷著向合成製劑和生物相似藥的重大轉變，這主要受市場對更高純度、更高濃度和更佳安全性的需求所驅動。這些先進的製劑最大限度地降低了污染風險，並且在臨床應用中更方便、更可靠。隨著醫療保健系統將品質和效率置於首位，這一趨勢不僅提高了現有催產素產品的標準，也有助於提升其在全球範圍內的擴充性和可及性。因此，向合成製劑和生物相似藥的轉變預計將重塑市場動態，並為催產素滿足不同人群和地區日益成長的治療需求奠定基礎。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭資訊

前五大公司對比
主要企業的市場定位（2025 年）
主要市場參與者所採取的策略
近期市場趨勢
公司市佔率分析（2025 年）
主要企業公司簡介
- 公司詳情
- 產品系列分析
- 依業務板塊進行公司股票分析
- 2023-2025年營收年比比較

主要企業簡介

Novartis AG
Pfizer Inc.
Fresenius Kabi LLC
Ferring BV
Hikma Pharmaceuticals PLC
Endo International plc.（Par Sterile Products, LLC）
Teva Pharmaceutical Industries Ltd.
Mylan NV
Sun Pharmaceutical Industries Ltd.
Yuhan Corporation
Wockhardt Ltd.
Weefsel Pharma
EVER Pharma

結論與建議

簡介目錄

Product Code: SQMIG35I2465

Global Oxytocin Market size was valued at USD 4.31 Billion in 2024 and is poised to grow from USD 4.53 Billion in 2025 to USD 6.74 Billion by 2033, growing at a CAGR of 5.1% during the forecast period (2026-2033).

The global oxytocin market is significantly influenced by rising childbirth complications and an intensified emphasis on maternal health in developing areas. An enhanced understanding of safe labor management practices, along with increasing oxytocin usage for labor induction and postpartum hemorrhage treatment, is propelling market expansion. The introduction of various drug delivery methods, such as injectables and nasal sprays, is improving accessibility and catering to patient preferences. Notable trends include a shift towards synthetic and biosimilar oxytocin formats, which are valued for their consistent quality and reduced contamination risk. However, the market faces challenges including stringent regulatory processes, safety concerns, and cost barriers, particularly in low-income regions, alongside competition from alternative drugs and herbal remedies that may limit oxytocin's market presence.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Oxytocin market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Oxytocin Market Segments Analysis

Global Oxytocin Market is segmented by Indication, Distribution Channel, Route of Administration and region. Based on Indication, the market is segmented into Antepartum and Postpartum. Based on Distribution Channel, the market is segmented into Hospitals, Pharmacies, Drug Stores and Online Pharmacies. Based on Route of Administration, the market is segmented into Parenteral, Intranasal and mucosal. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Oxytocin Market

One of the key market drivers for the global oxytocin market is the increasing prevalence of various childbirth complications and the rising demand for safe delivery practices. Oxytocin is widely used in obstetric care to induce labor, control postpartum hemorrhage, and facilitate uterine contractions, which enhances maternal and neonatal health outcomes. Additionally, the growing awareness among healthcare professionals about the importance of oxytocin in managing labor and delivery complications is driving its adoption across hospitals and maternity clinics. Furthermore, the expanding field of research into oxytocin's potential therapeutic applications beyond childbirth, including psychiatric and social behaviors, is also fueling market growth.

Restraints in the Global Oxytocin Market

One key market restraint for the global oxytocin market is the stringent regulatory landscape governing its production and use in medical applications. Regulatory bodies impose rigorous safety and efficacy standards that can delay approval processes for new formulations and therapies, thereby limiting the availability of innovative oxytocin-based treatments. Additionally, concerns surrounding the misuse of oxytocin, particularly in the context of unregulated usage in agriculture or veterinary applications, further complicate regulatory oversight. This can discourage investment and research in the oxytocin market, ultimately hindering growth and limiting accessibility for patients who may benefit from such therapies.

Market Trends of the Global Oxytocin Market

The Global Oxytocin market is experiencing a significant shift towards synthetic and biosimilar formulations, driven by the demand for higher purity, enhanced concentration, and improved safety profiles. These advanced formulations minimize contamination risks, making them more user-friendly and reliable in clinical settings. As healthcare systems prioritize quality and efficiency, this trend not only elevates the standard of oxytocin products available but also enhances scalability and accessibility worldwide. Consequently, the movement towards synthetic and biosimilar options is poised to redefine market dynamics, ensuring that oxytocin can meet the growing therapeutic needs across diverse demographics and regions.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis

Global Oxytocin Market Size by Indication & CAGR (2026-2033)

Market Overview
Antepartum
Postpartum

Global Oxytocin Market Size by Distribution Channel & CAGR (2026-2033)

Market Overview
Hospitals
Pharmacies
Drug Stores
Online Pharmacies

Global Oxytocin Market Size by Route of Administration & CAGR (2026-2033)

Market Overview
Parenteral
Intranasal
mucosal

Global Oxytocin Market Size & CAGR (2026-2033)

North America (Indication, Distribution Channel, Route of Administration)
- US
- Canada
Europe (Indication, Distribution Channel, Route of Administration)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Indication, Distribution Channel, Route of Administration)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Indication, Distribution Channel, Route of Administration)
- Brazil
- Rest of Latin America
Middle East & Africa (Indication, Distribution Channel, Route of Administration)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Novartis AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pfizer Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Fresenius Kabi LLC
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ferring B.V.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hikma Pharmaceuticals PLC
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Endo International plc. (Par Sterile Products, LLC)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Teva Pharmaceutical Industries Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Mylan N.V.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sun Pharmaceutical Industries Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Yuhan Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Wockhardt Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Weefsel Pharma
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
EVER Pharma
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments